Kromek Group PLC (LON:KMK) has been awarded an extension of its high-volume production contract with the Defense Advanced Research Projects Agency (DARPA), an agency of the US Department of Defense.
The AIM-listed radiation monitoring company said the extension, worth US$1.6mln, will be delivered over an 18-month period and will involve additional enhancements to the company’s D3S equipment already deployed at DARPA.
READ: Kromek CEO confident of EBITDA break-even this financial year
Kromek added that its D3S products will be used to provide greater operational capability and information detail to DARPA’s SIGMA programme, an initiative aimed at preventing attacks involving radiological ‘dirty bombs’ and other nuclear threats in the US and globally.
Since the beginning of its contract in February 2016, Kromek said 10,000 of its D3S units had been delivered successfully.
Dr Arnab Basu, Kromek chief executive, said: "Having our D3S detectors positioned as a central pillar in DARPA's SIGMA programme is a testament to the capabilities of our state-of-the art technology and the strength of our relationship with DARPA.”
He added: “With field tests continuing in the US and across the globe, the D3S is gaining traction as an invaluable tool to help cities detect and counter the threat of dirty-bomb attacks."